ArticleCureus2025

Neurologic Adverse Events Associated With T-cell Engager Therapy in Multiple Myeloma: A Pharmacovigilance Study.

Muhammad Atif Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.